Nucleus Tractus Solitarius Neurons Activated by Hypercapnia and Hypoxia Lack Mu Opioid Receptor Expression

Area of Science:

• Neuroscience
• Respiratory Physiology
• Pharmacology

Background:

• Opioid-induced respiratory depression is a major clinical concern.
• The nucleus of the solitary tract (NTS) is implicated in opioid-induced chemoreflex impairment.
• Mu opioid receptors in the NTS are hypothesized to mediate these effects.

Purpose of the Study:

• To investigate whether caudal NTS neurons activated by chemoreflex challenges express mu opioid receptors.
• To determine if opioid-activated neurons in the NTS overlap with neurons activated by chemoreflex stimuli.
• To elucidate the mechanism of opioid-induced chemoreflex depression within the NTS.

Main Methods:

• Utilized genetic labeling to identify mu opioid receptor-expressing neurons in the NTS.
• Employed cFos immunohistochemistry to assess neuronal activation following hypercapnia, hypoxia, and morphine.
• Examined the spatial distribution of activated NTS neurons in relation to mu opioid receptor expression.

Main Results:

• Hypoxia and hypercapnia predominantly activated NTS neurons lacking mu opioid receptors.
• Morphine administration during hypercapnia resulted in cFos expression in distinct neuronal populations.
• No significant overlap was observed between neurons activated by chemoreflex challenges and those activated by morphine.

Conclusions:

• Opioid effects on NTS neurons during chemoreflex challenges appear to be indirect.
• Mu opioid receptors on afferent inputs or inhibitory interneurons may mediate opioid-induced chemoreflex impairment.
• Findings suggest novel targets for mitigating opioid-induced respiratory depression.